Related references
Note: Only part of the references are listed.The impact of pharmacological and lifestyle interventions on body weight in people with type 1 diabetes: A systematic review and meta-analysis
Saniya Tandon et al.
DIABETES OBESITY & METABOLISM (2021)
Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis
Ioannis Avgerinos et al.
DIABETES OBESITY & METABOLISM (2021)
GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity
Hoda Kadouh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial
Thomas F. Dejgaard et al.
DIABETES OBESITY & METABOLISM (2020)
Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26-week randomized controlled trial; mechanisms of weight loss
Husam Ghanim et al.
DIABETES OBESITY & METABOLISM (2020)
BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox
Jon Edqvist et al.
DIABETES CARE (2019)
Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy
Christina Brock et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018
Nicole C. Foster et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Beyond glycaemic control: A cross-over, double-blinded, 24-week intervention with liraglutide in type 1 diabetes
Marie-Christine Dube et al.
DIABETES OBESITY & METABOLISM (2018)
The Food Environment, Preference, and Experience Modulate the Effects of Exendin-4 on Food Intake and Reward
Ricardo Mella et al.
OBESITY (2017)
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
John Blundell et al.
DIABETES OBESITY & METABOLISM (2017)
Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial
Bo Ahren et al.
DIABETES CARE (2016)
Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks
Nitesh D. Kuhadiya et al.
DIABETES CARE (2016)
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
Chantal Mathieu et al.
DIABETES CARE (2016)
The Psychosocial Burden of Obesity
David B. Sarwer et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2016)
Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
Thomas Fremming Dejgaard et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study
Christian S. Frandsen et al.
DIABETES CARE (2015)
Current State of Type 1 Diabetes Treatment in the US: Updated Data From the T1D Exchange Clinic Registry
Kellee M. Miller et al.
DIABETES CARE (2015)
Pooled Results From 5 Validation Studies of Dietary Self-Report Instruments Using Recovery Biomarkers for Energy and Protein Intake
Laurence S. Freedman et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
Effects of GLP-1 on appetite and weight
Meera Shah et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2014)
Relationship Between Overweight and Obesity With Hospitalization for Heart Failure in 20,985 Patients With Type 1 Diabetes: A population-based study from the Swedish National Diabetes Registry
Daniel Vestberg et al.
DIABETES CARE (2013)
Use of Non-Insulin Therapies for Type 1 Diabetes
Satish K. Garg et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2013)
Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes
Michael Horowitz et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Temporal patterns in overweight and obesity in Type 1 diabetes
B. Conway et al.
DIABETIC MEDICINE (2010)
Body mass index, waist circumference and waist: hip ratio as predictors of cardiovascular risk-a review of the literature
R. Huxley et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2010)
Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea
J. C. Seidell
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2010)
The effect of obesity on health outcomes
John B. Dixon
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
J. Jendle et al.
DIABETES OBESITY & METABOLISM (2009)
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
Gary Whitlock et al.
LANCET (2009)
Abdominal and Gynoid Fat Mass Are Associated with Cardiovascular Risk Factors in Men and Women
Peder Wiklund et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Insulin-associated weight gain in diabetes - causes, effects and coping strategies
David Russell-Jones et al.
DIABETES OBESITY & METABOLISM (2007)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Data collected on maternal dietary exposures in the Danish National Birth Cohort
Sjurdur Frodi Olsen et al.
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2007)
Relative validity of fruit and vegetable intake estimated by the food frequency questionnaire used in the Danish National Birth Cohort
Tina B. Mikkelsen et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2007)
Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort
Tina B. Mikkelsen et al.
PUBLIC HEALTH NUTRITION (2006)
Body fat and fat-free mass and all-cause mortality
J Bigaard et al.
OBESITY RESEARCH (2004)
Share Paper
